Compugen (NASDAQ:CGEN) Downgraded by StockNews.com

StockNews.com cut shares of Compugen (NASDAQ:CGEN – Free Report) from a hold rating to a sell rating in a research note released on Thursday. Separately, Stifel Nicolaus upped their price objective on shares of Compugen from $3.00 to $4.00 and gave the company a buy rating in a report on Tuesday, December 19th. Two analysts […]

Related Keywords

Israel ,United States ,Stifel Nicolaus ,Goldman Sachs Group Inc ,Kingsview Wealth Management ,Compugen Company Profile ,Nasdaq ,Compugen Ltd ,Silverarc Capital Management ,Compugen ,Free Report ,Get Free Report ,Capital Management ,Wealth Management ,Goldman Sachs Group ,Sachs Group ,Compugen Daily ,Nasdaq Cgen ,Ocgen ,Medical ,Downgrade ,Stocknews Com ,